Literature DB >> 11424257

A consumer trip into the world of the DALY calculations: an Alice-in-Wonderland experience.

H Bastian1.   

Abstract

For a consumer advocate, entering the world of the disability-adjusted life years (DALYs) calculations was a surreal experience. What began with the noble aim of working out how to overcome the tyranny of death as the only way of 'measuring' health, has led to an exercise where people weigh the relative value of health conditions without death as a feature. However, life-threatening diseases, if they no longer carry the threat of death, are no longer themselves. These valuations of 'altered health states' then, can become absurd. While data often fail to measure real life very well, and distort as well as illuminate, the ranking of disease in this way is particularly problematic. It has been said to disadvantage the poor, the very young and very old, and women. It privileges short-term interventions over prevention and long-term strategies. Can this really improve decision-making about resource allocation in health?

Entities:  

Mesh:

Year:  2000        PMID: 11424257     DOI: 10.1016/s0968-8080(00)90012-0

Source DB:  PubMed          Journal:  Reprod Health Matters        ISSN: 0968-8080


  3 in total

1.  Cost/DALY averted in a small hospital in Sierra Leone: what is the relative contribution of different services?

Authors:  Richard A Gosselin; Amardeep Thind; Andrea Bellardinelli
Journal:  World J Surg       Date:  2006-04       Impact factor: 3.282

2.  Asymmetries of poverty: why global burden of disease valuations underestimate the burden of neglected tropical diseases.

Authors:  Charles H King; Anne-Marie Bertino
Journal:  PLoS Negl Trop Dis       Date:  2008-03-26

3.  Time to include burden of surgical injuries after disasters in the Global Surgery agenda? An assessment of DALYs and averted burden by surgery after the 2008 Wenchuan earthquake.

Authors:  Jose Manuel Rodriguez-Llanes; Lina Hellman; Qi Wu; Barbara van den Oever; Liang Pan; Manuel Albela Miranda; Gao Chen; De-Sheng Zhang; Debarati Guha-Sapir; Johan Von Schreeb
Journal:  BMJ Glob Health       Date:  2018-10-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.